![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 48, 45160-45167, November 30, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
From the
Department of Cellular Biochemistry,
Max-Planck-Institut für Biochemie and the
§ Max-Planck-Institut für Neurobiologie, D-82152
Martinsried, Germany and the ¶ Department of Biochemistry and
Molecular Biology, University of Miami School of Medicine,
Miami, Florida 33101
Received for publication, May, 29, 2001, and in revised form, July 18, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Induced expression of heat shock proteins
(Hsps) plays a central role in promoting cellular survival after
environmental and physiological stress. We have previously shown that
scrapie-infected mouse neuroblastoma (ScN2a) cells fail to induce the
expression of Hsp72 and Hsp28 after various stress conditions. Here we
present evidence that this impaired stress response is due to an
altered regulation of HSF1 activity. Upon stress in ScN2a cells, HSF1 was converted into hyperphosphorylated trimers but failed to acquire transactivation competence. A kinetic analysis of HSF1 activation revealed that in ScN2a cells trimer formation after stress was efficient, but disassembly of trimers proceeded much faster than in the
uninfected cell line. Geldanamycin, a Hsp90-binding drug, significantly
delayed disassembly of HSF1 trimers after a heat shock and restored
stress-induced expression of Hsp72 in ScN2a cells. Heat-induced Hsp72
expression required geldanamycin to be present; following removal of
the drug ScN2a cells again lost their ability to mount a stress
response. Thus, our studies show that a defective stress response can
be pharmacologically restored and suggest that the HSF1 deactivation
pathway may play an important role in the regulation of Hsp expression.
Stress response mechanisms are essential for the maintenance of
cellular integrity and viability. Diverse stress conditions converge to
enhance the synthesis of heat shock proteins
(Hsps),1 many of which
function as molecular chaperones in protein biosynthesis, folding,
assembly, translocation, and degradation (1-6). In addition to
preventing proteotoxic damage, Hsps also appear to be involved in
antiapoptotic pathways (7-9). In animal models as well as in
vertebrate cell culture models, overexpression of specific Hsps
decreases cytotoxicity induced by different environmental stress
conditions, including thermal and oxidative challenges, ischemia, or
exposure to toxic chemicals (reviewed in Refs. 10-12).
In the nervous system, Hsps are thought to play an important role in a
variety of pathophysiological states, including neurodegenerative diseases, cerebral ischemia, epilepsy, and trauma. Aged cells exhibit a
decreased ability to induce Hsp72 in response to stress (13). This
compromised induction of Hsp expression may reflect an adaptive
cellular response. Aged cells and cells affected by age-related
diseases (e.g. Alzheimer's disease, Huntington's disease, Parkinson's disease, and prion diseases) are characterized by an
increased amount of abnormally folded proteins. If the stress response
were functional in these cells, Hsp72 would be expressed permanently at
high levels and may interfere with the apoptotic program and thereby
with the elimination of diseased cells (14). Notably, the threshold for
stress induction is significantly raised in cells exposed to a
prolonged (moderate) stress (Ref. 15 and references therein).
At the molecular level, the different physiological and environmental
stressors are integrated through the activation of a single
transcription factor, the heat shock transcription factor 1 (HSF1). In
unstressed mammalian cells, HSF1 exists in an inert nontrimeric form.
In response to stress HSF1 assembles into homotrimers, binds to
specific heat shock element (HSE) sequences present within inducible
Hsp genes, and becomes hyperphosphorylated (reviewed in Refs. 16-19).
Acquisition of HSE binding activity by trimer formation, however, is
not sufficient to render HSF1 transactivation-competent (20-25),
suggesting that factor activation occurs at least in two steps:
trimerization and acquisition of DNA binding activity followed by
induction of transcriptional competence. HSF1 trimer assembly is
negatively regulated by the molecular chaperone Hsp90 (26-28) that may
interact with the three hydrophobic repeat sequences of the
transcription factor (29). Repression of the last step of HSF1
activation that ultimately leads to transactivation-competent factor
appears to be mediated through a regulatory domain defined by Green
et al. (30) and Zuo et al. (24). Although this
final regulation step is not yet understood, it appears to involve
chaperone interactions (28, 31, 32) as well as
phosphorylation/dephosphorylation events (33-38).
Scrapie-infected mouse neuroblastoma (ScN2a) cells have proved useful
to study certain aspects of prion diseases in cell culture. In contrast
to uninfected N2a cells ScN2a cells propagate mouse prions and
accumulate intracellular protein aggregates composed of proteinase K
(PK)-resistant PrPSc. We previously reported that
stress-induced expression of Hsp72 and Hsp28 is impaired in a ScN2a
cell line, whereas uninfected N2a cells can mount an effective stress
response (39). In this study, we show that HSF1 trimers formed in ScN2a
cells after stress are rapidly disassembled and lack transactivation
competence. We demonstrate that the Hsp90-binding drug geldanamycin
corrects the defective regulation of HSF1 activity after heat stress in ScN2a cells.
Recombinant Plasmid DNAs--
Expression constructs for wtHSF1,
Antibodies--
Polyclonal anti-PrP antiserum A4 was raised
against recombinant full-length PrP that was expressed and purified
from bacteria (42). The mouse monoclonal antibody specific for
inducible Hsp72 (C92) has been characterized previously (43). The mouse
monoclonal antibody N27 (clone N27F3-4) that identifies both the
inducible and the constitutive form of Hsp70, the rabbit polyclonal
antibody against Hsp90 (clone 2D12), and the mouse monoclonal antibody against Hsp90 (clone AC88) were purchased from StressGen, and the mouse
monoclonal antibody specific for p23 (clone JJ3) was purchased from
Affinity Bioreagents.
Cell Culture--
N2a and ScN2a cells were grown in minimum
essential Eagle's medium supplemented with antibiotics (1 unit/ml penicillin G and 1 mg/ml streptomycin) and 10% fetal calf
serum. N2a cells are an immortalized neuroblastoma cell line (ATCC
number CCl 131). ScN2a cells were established by infecting N2a cells
with an enriched preparation of prions isolated from the brains of
scrapie-infected mice.
Transfections--
One day before transfection, the cells were
plated at a density of 1 × 106 cells/35-mm plate in
supplemented medium. The cells were transfected by a liposome-mediated
method using LipofectAMINE PlusTM Reagent (Life
Technologies, Inc.). In brief, 1 µg of plasmid DNA was precomplexed
with 6 µl of Plus Reagent in 100 µl of Optimem (Life Technologies,
Inc.) at room temperature for 15 min. 8 µl of LipofectAMINE in 100 µl of Optimen were added and incubated for another period of 15 min.
After adding 800 µl of Optimem, the DNA-liposome-Optimem mixture was
poured onto the rinsed cells. After incubation of cells at
37 °C for 3 h, 1 ml of supplemented medium was added.
Stress Treatment--
For a heat shock cell culture, dishes were
placed in a water bath for the time and temperature indicated.
Geldanamycin was dissolved in Me2SO, added to the
cells 2 h prior to a heat shock, and removed after 3 h. The
controls were treated with Me2SO alone.
Detergent Solubility Assay--
As described by Tatzelt et
al. (44), the cells were washed twice with cold phosphate-buffered
saline (PBS), scraped from the plate, pelleted by centrifugation, and
lysed in cold buffer A (0.5% Triton X-100 and 0.5% sodium
deoxycholate in PBS). The lysate was centrifuged at 15,000 × g for 20 min at 4 °C; the supernatants and pellets were
examined by immunoblotting.
Proteolysis Experiments--
N2a and ScN2a cells were lysed as
described above. To the lysate (50 µg of total protein) proteinase K
(1 µg) was added, and the samples were incubated at 30 °C for 30 min. The reaction was terminated by the addition of Pefabloc SC (Roche
Molecular Biochemicals) and boiling in Laemmli sample buffer. Residual
PrP was detected by Western blotting.
Western Blot Analysis--
Detergent-fractionated cell lysates
were size fractionated by SDS-polyacrylamide gel electrophoresis, and
the proteins were transferred to nitrocellulose (Protran BA 85, Schleicher & Schüll) by electroblotting. The nitrocellulose
membranes were blocked with 5% nonfat dry milk in PBST (PBS containing
0.1% Tween 20) for 30 min at room temperature and subsequently
incubated with primary antibody in PBST for 16 h at 4 °C. After
extensive washing with PBST, the membranes were incubated with
horseradish peroxidase-conjugated secondary antibody for 40 min at room
temperature. Following washing with PBST, the antigen was detected with
the enhanced chemoluminescence detection system (Amersham Pharmacia
Biotech) as specified by the manufacturer.
Luciferase and Northern Blot Analysis--
Cytosolic RNA was isolated using a
commercially available kit (RNeasy mini kit; Qiagen). For each sample,
5 µg of cytoplasmatic RNA were separated electrophoretically on a 1%
agarose/formaldehyde gel, transferred to a positively charged nylon
membrane (Hybond N+; Amersham Pharmacia Biotech), and cross-linked by
UV irradiation. For hybridization the nylon membranes were
prehybridized in hybridization buffer (5× SSC, 10× Denhardt's
solution, 50% formamide, 1% SDS, 1% bovine serum albumin, 200 mg/ml
denaturated salmon sperm DNA) at 45 °C for 2 h, followed by an
incubation in hybridization buffer with a probe containing the
32P-labeled DNA probe specific for Hsp72 (45) or mouse PrP
overnight at 45 °C. The probe was prepared by using the random
primed DNA synthesis (oligolabeling kit; Amersham Pharmacia Biotech) in
the presence of [ Electrophoretic Mobility Shift Assays--
Preparation of cell
extracts and gel shift assays were performed as previously described by
Baler et al. (46). Whole cell extracts were prepared by
freezing pellets of PBS-washed cells in liquid nitrogen. After thawing
the pellet was resuspended in two packed cell volumes of buffer C (20 mM HEPES, pH 7.9, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl
fluoride, 10 µg leupeptin/ml, 0.01 unit aprotinin/ml, 25% glycerol,
0.1% Igepal CA-630; Sigma), and the concentration of NaCl was adjusted
to 0.38 M. After 10 min of incubation on ice, the extract
was centrifuged at 4 °C for 15 min at 10,000 × g.
For the binding reaction 20 µg of protein was added to 10 µl of 2×
Kingston buffer (24 mM HEPES, pH 7.9, 120 mM
KCl, 4 mM MgCl2, 0.24 mM EDTA, 0.6 mM phenylmethylsulfonyl fluoride, 0.6 mM
dithiothreitol, and 24% glycerol), 1 µl of sonicated salmon sperm
DNA (1 mg/ml), 1 µl of poly(dI-dC) (1 mg/ml), and 1.75 pmol of
32P-labeled, double-stranded HSE oligonucleotide (47). The
final volume of the mixture was adjusted to 20 µl with water.
Double-stranded HSE oligonucleotides were end-labeled with
[ Indirect Immunofluorescence--
N2a and ScN2a cells were grown
on glass coverslips and fixed by immersion in cold methanol for 10 min.
The fixed cells were incubated with the anti-Hsp72 antibody C92
(dilution of 1:50) or with the monoclonal anti-Hsp90 antibody (dilution
of 1:100) in PBS containing 1% bovine serum albumin for 45 min at
37 °C. After extensive washing with PBS, an incubation with
rhodamine-conjugated anti-mouse antibodies (Dianova) (dilution 1:200)
followed at 37 °C for 30 min. The washed coverslips were mounted
onto glass slides and examined by phase contrast and fluorescence microscopy.
Scrapie-infected N2a Cells Do Not Express Inducible Hsp72 and Hsp28
after Heat Shock--
ScN2a cells provide a system to study the
accumulation of infectious PrPSc in cell culture (48-50).
In addition to productive propagation of detergent insoluble,
PK-resistant, and infectious PrPSc, the same cells were
described by us to be impaired in the stress-induced expression of
Hsp72 and Hsp28 (39). It is important to note that the deregulated
stress response in ScN2a cells was restricted to the two most highly
inducible stress proteins Hsp72 and Hsp28; exposure of ScN2a cells to
various stress conditions resulted in increased expression of Hsp73,
Hsp90, grp75, grp78(BiP), and grp94, as determined by two-dimensional
gel electrophoresis (see Fig. 2 in Ref. 39). The deregulated expression
of Hsp72 in ScN2a cells is again illustrated by the experiment shown in
Fig. 1. Three independently established
ScN2a cell lines were analyzed with respect to propagation of
PrPSc and expression of Hsp72 subsequent to heat treatment.
In contrast to uninfected N2a cells, all of the three ScN2a cell lines
harbored significant amounts of detergent-insoluble (Fig.
1A,
To rule out that expression levels of proteins that are involved in the
regulation of HSF1 activity were different in N2a and ScN2a cells, we
performed a Western blot analysis with antibodies against Hsp73, Hsp90,
and p23. As shown in Fig. 1B, no obvious differences could
be detected in the relative amounts of the respective proteins. This
analysis also indicated that in ScN2a cells the apparent lack of Hsp72
expression after stress is not accompanied by increased constitutive
levels of Hsp73, which could compensate for the impaired Hsp72
expression. The following experiments, which attempt to analyze
the underlying mechanism, were carried out using ScN2a cell line I.
Activation of an Exogenous Hsp72 Promoter by Thermal Challenge Is
Impaired in ScN2a Cells--
We have previously shown that trimeric,
hyperphosphorylated HSF1 formed in heat-shocked ScN2a cells failed to
transactivate the major Hsp72 gene (39). To test the possibility that a
defect in the endogenous Hsp72 gene was responsible for the absence of induced Hsp72 expression, we performed transient transfection experiments with a DNA construct (HSE-Luc) expressing firefly luciferase under the control of the highly heat-inducible promoter of
the human Hsp70B gene (40). Transfected cells were subjected to heat
for different periods of time and analyzed for luciferase activity. In
N2a cells, luciferase activity increased greatly after heat shock.
Levels attained were proportional to the duration of the thermal
challenge. In ScN2a cells, luciferase activities were significantly
lower than in N2a cells under all heat shock conditions tested (Fig.
2A). Initially, we were
puzzled about the activation of HSE-Luc in ScN2a cells, especially
under more severe heat shock conditions. This activation was most
likely due to the presence of trimeric HSF1 that lacks the competence to transactivate the endogenous Hsp72 promoter but induces a weak transcription from the transfected HSE-Luc construct. Support for this
notion was derived from experiments in which N2a and ScN2a cells were
co-transfected with HSE-Luc and an expression construct for either wild
type (wt)HSF1 or a HSF1 mutant denoted
Co-transfection of the
In conclusion, these experiments indicated that ScN2a cells are
significantly impaired to induce expression from Hsp promoters using
their own HSF1. It appears therefore that the virtual inability of
ScN2a cells to induce expression of Hsp72 and Hsp28 during stress is
caused by a defect in the activation of endogenous HSF1.
Geldanamycin Restores the Deregulated Heat Shock Response in ScN2a
Cells--
To get insight into the regulation of HSF1 activity in
ScN2a cells, we tried to modulate the heat shock response
pharmacologically. Geldanamycin, a benzoquinone ansamycin, interacts
with Hsp90 and interferes with Hsp90-dependent signal
transduction pathways (51-59). Recently, Hsp90 has been described to
be involved in the negative regulation of HSF1 activity (26-28).
Consequently, we examined the effect of geldanamycin on the expression
of Hsp72 in N2a and ScN2a cells. The cells were grown on glass
coverslips at 37 °C and then subjected to treatment by heat
(44 °C for 20 min), geldanamycin (5 µM for 3 h),
or both. In the latter case the heat shock was applied 2 h after
geldanamycin was added. After further incubation at 37 °C for
16 h in fresh medium, expression of Hsp72 was detected by indirect
immunofluorescence. The results showed that after thermal stimulation
the entire population of N2a cells expressed Hsp72, whereas no ScN2a
cell stained positive for Hsp72 under the same conditions.
Interestingly, in N2a cells the effect of geldanamycin on the
expression of Hsp72 was restricted to a small subpopulation of cells
(Fig. 3A, N2a, GA). A similar discrete pattern of Hsp72 expression was detected in ScN2a cells subjected to
combined thermal and geldanamycin treatment (Fig. 3A,
ScN2a, GA + 44 °C). This restricted expression
of Hsp72 might reflect a cell cycle-dependent action of
geldanamycin, which has been shown to interfere with the expression of
different cyclins (60-63). Unfortunately, it was not possibly to
verify this speculation because the ScN2a cells did not survive
geldanamycin and heat treatment after synchronization. In summary, the
ScN2a cell line was found to be a homogenous population with respect to
the impaired stress response. Heat stress-inducible expression of Hsp72
could be restored by short term incubation of cells with the
Hsp90-binding drug geldanamycin. Expression analysis indicated that the
relative amount of Hsp90 was similar in N2a and ScN2a cells. (Fig.
1B). To investigate possible differences in the subcellular
localization of Hsp90, we performed indirect immunofluorescence
experiments. In N2a cells a diffuse cytosolic Hsp90 staining was
observed, and we could not find differences between untreated and
geldanamycin-treated N2a cells (Fig. 3C, N2a). In
ScN2a cells, however, Hsp90 distribution was predominantly
inhomogenous, reminiscent of aggresomal compartmentalization. Interestingly, after geldanamycin treatment this discrete pattern of
accumulated Hsp90 disappeared, now resembling the uniform pattern found
in N2a cells (Fig. 3C, ScN2a). Notably, in this
experiment geldanamycin was used in the same concentration that
restored the stress-induced expression of Hsp72. Additional proof of an impaired function of Hsp90 in ScN2a cells was obtained by analyzing the
activation pathway of the glucocorticoid receptor, which is regulated
similarly to HSF1 (65). After transfection of a GRE-Luc reporter
construct, stimulation of the endogenous glucocorticoid receptor by
dexamethasone resulted in a more than 55-fold luciferase activity in
N2a cells, whereas in ScN2a cells luciferase activity was increased
only 9-fold (Fig. 3D). Of note, there were no differences in
the levels of endogenous glucocorticoid receptor between the two cell
lines (data not shown).
Overexpression of Geldanamycin Delays Disassembly of HSF1 Trimers after Heat
Shock--
To determine the mechanism by which geldanamycin restores
the defective heat response, we analyzed transcription of the
Hsp72-specific mRNA by Northern blotting. In N2a cells pretreatment
with geldanamycin significantly prolonged Hsp72 transcription after a
heat shock (Fig. 4A). After
heat shock Hsp72-specific mRNA rapidly appeared in the cytosol and
could be detected for about 2 h. (Fig. 4A, hs). If geldanamycin was applied 2 h prior to the heat
shock, Hsp72-specific mRNA could now be detected for up to 8 h
after the thermal stimulus (Fig. 4A, hs + GA). In
ScN2a cells neither heat shock nor geldanamycin alone was sufficient to
induce transcription; however, a combination of both stimuli resulted
in the appearance of Hsp72-specific mRNA (Fig. 4B,
hs + and GA +), corroborating our analysis of
Hsp72 expression by immunofluorescence (Fig. 3A, ScN2a, GA + 44 °C). Thus, the Northern blot
analysis was consistent with the results on the expression of Hsp72
obtained by immunofluorescence and indicated that geldanamycin
prolonged transcription of Hsp72-specific mRNA in heat-treated N2a
cells.
We next examined HSF1 trimerization and trimer disassembly in N2a and
ScN2a cells exposed to a heat shock in the presence or absence of
geldanamycin. The electrophoretic mobility shift assay is based on the
HSE binding activity specific for HSF1 trimers. We had previously shown
that the relative levels of HSF1 and the formation of
hyperphosphorylated HSF1 trimers after stress was comparable in N2a and
ScN2a cells (see Fig. 3 in Ref. 39). To extend these earlier studies,
N2a and ScN2a cells were treated at 44 °C for 20 min, returned to
37 °C, and examined thereafter at various time points. Formation of
HSF1 trimers was detected 20 min after the heat shock in both N2a and
ScN2a cells (Fig. 5A,
lane 2). However, whereas in N2a cells HSF1 trimers were
still present 60 min after the heat shock, they had already been
disassembled in ScN2a cells at this time point (Fig. 5A,
lane 4). In the presence of geldanamycin, disassembly of
HSF1 trimers was significantly delayed, and the kinetics of HSE binding
activity were now essentially the same in N2a and ScN2a cells. In both
cell types, HSF1 trimers were present for at least 3 h after heat
shock (Fig. 5B, lane 6). Of note, the relative
amount of HSF1 trimers in ScN2a cells after a heat shock was not
increased by geldanamycin (Fig. 5C). As a control, we
analyzed the DNA binding activity of the transcription factor AP1 and
did not observe qualitative or quantitative differences between N2a and
ScN2a cells (data not shown).
Induced expression of stress proteins provides a powerful defense
mechanism to ensure cellular survival after environmental and
physiological stress conditions. HSF1, the transcription factor that
mediates the stress response is known; however, some aspects of its
regulation remain to be elucidated. The studies reported here indicate
that the defective stress response in scrapie-infected neuroblastoma
(ScN2a) cells is due to an impairment of HSF1 function and can be
restored by the Hsp90-binding drug geldanamycin.
Geldanamycin Corrects a Defect in HSF1 Regulation--
ScN2a cells
are characterized by a defective stress-induced expression of Hsp72 and
Hsp28. Inducibility of other stress-regulated Hsps as well as
constitutive Hsps levels are comparable with those of uninfected N2a
cells. In this study, the underlying mechanism of the impaired
heat-induced expression of Hsp72 in ScN2a cells could be attributed to
an impaired activation of endogenous HSF1. Upon heat treatment trimeric
hyperphosphorylated HSF1 was formed in ScN2a cells; however, HSF1
trimerization and HSE binding was not sufficient to induce expression
of Hsp72. Interestingly, in transfection experiments with a
heat-regulated reporter construct (HSE-Luc), we observed a weak
activation of the promoter. Co-transfection experiments with wtHSF1
provided a plausible explanation for this observation. Activation of
HSE-Luc by overexpression of wtHSF1, which generates trimeric HSF1, was
in the same range as activation by heat treatment, supporting the view
that HSF1 is partially activated after stress in ScN2a cells.
Activation of HSE-Luc in ScN2a cells might be due to a higher affinity
of HSF1 trimers to the transfected HSE-Luc promoter or to a high copy
number of HSE-Luc plasmids present after transient transfection.
Notably, a constitutively active mutant of HSF1 (
Initial in vitro studies established a physical interaction
between Hsp90 and HSF1 (69, 70). More recently, Hsp90 was shown to act
as a repressor of HSF1 trimerization in an in vitro HeLa
cell extract system (27) and in the Xenopus oocyte model system (26, 28). To modulate Hsp90 function in ScN2a cells we used
geldanamycin that has been described previously to promote formation of
HSF1 trimers (27, 71, 72). After a short term treatment with
geldanamycin, heat-induced expression of Hsp72 was restored in a
subpopulation of ScN2a cells. This recovery was paralleled by a
striking change in the subcellular distribution of Hsp90. Whereas in
N2a cells Hsp90 was distributed homogenously in the cytosol, in ScN2a
cells Hsp90 was found predominantly in aggresome-like structures, which
disappeared after geldanamycin treatment. These findings suggest a
deregulation of Hsp90 function in ScN2a cells. Further support for a
dysfunction of Hsp90 in ScN2a cells was provided by the analysis of
another Hsp90-regulated pathway, the activation of the glucocorticoid
receptor. In contrast to N2a cells, dexamethasone-induced activation of
the glucocorticoid receptor was significantly suppressed in ScN2a cells.
The functional HSE binding assay indicated a possible molecular basis
for the effect of geldanamycin on the heat-induced expression of Hsp72.
Whereas in both N2a and ScN2a cells HSF1 gained DNA binding competence
rapidly after a heat shock, HSF1 trimer disassembly occurred much
faster in ScN2a cells. In presence of geldanamycin, however, trimer
disassembly was delayed, and the kinetics of HSF1 trimer disassembly
were now very similar in N2a and ScN2a cells. Notably, the relative
amount of HSF1 trimers formed after a heat shock in ScN2a cells was not
enhanced by geldanamycin.
Implications for the Stress Response--
The study described
above is, to our knowledge, the first demonstration that a defective
heat shock response can be restored in vivo by a specific
modulator of Hsp90 function. It is important to note that Hsp72
expression was absent in ScN2a cells under all heat shock conditions
tested as well as under other stressful conditions causing proteotoxic
damage such as oxidative stress and exposure to sodium arsenite or
amino acid analogs. Thus, the deregulation of HSF1 activity in ScN2a
cells could not be compensated simply by increasing the severity of the
stress. Our findings support previous reports indicating that Hsp90 is
a key regulator of HSF1 activity and provide new insights into the
stress-regulated expression of chaperones.
Two different models of how geldanamycin modulates regulation of HSF1
activity in ScN2a cells are supported by our results (Fig.
6). It has been suggested previously that
the activated HSF1 complex resembles steroid receptor complexes and
that HSF1 activity is regulated similarly to steroid receptors (70). In a recent report Bharadwaj et al. (28) supported this
hypothesis by showing that different constituents of the Hsp90
chaperone complex such as p23 and FKBP52 participate in the regulation
of HSF1 activity in Xenopus oocytes. Thus, it is conceivable
that HSF1 trimers in ScN2a cells lack transactivation competence
because the HSF1-Hsp90 chaperone complex has a different composition. Binding of geldanamycin to the HSF1-Hsp90 chaperone complex might induce dissociation of regulators from this complex that suppress the
transcriptional competence of trimeric HSF1. Alternatively, formation
of HSF1 trimers after stress might be qualitatively the same in both
cell lines, but the faster deactivation of HSF1 trimers in ScN2a cells
interferes with transactivation competence. The fact that geldanamycin
did not increase the relative amount of HSF1 trimers in ScN2a cells
after stress but rather prolonged their lifetime might favor the
kinetic model. The results obtained in transfection experiments with
wtHSF1 are in line with both models discussed above. Overexpression of
wtHSF1 could have provided a sufficient amount of trimeric HSF1 to
compensate for the accelerated deactivation of HSF1 trimers in ScN2a
cells. Alternatively, excessive HSF1 might absorb negative regulators,
thereby shifting the equilibrium toward the transactivation competent
form of HSF1. In summary, our data support a pivotal role of Hsp90 or a
Hsp90 chaperone complex in the regulation of HSF1 activity (Fig. 6) and
emphasize that the deactivation of HSF1 may play an important role in
regulating Hsp72 expression.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
HSF1, HSE-Luc,
-galactosidase, and GRE-Luc were described
previously (24, 40, 41). The luciferase reporter vector pGL3 control
was purchased from Promega.
-Galactosidase Assays--
1 µg of reporter
plasmid (HSE-Luc or GRE-Luc) was transfected into N2a and ScN2a cells.
24 h after transfection, the cells were heat shocked (HSE-Luc) or
incubated with dexamethasone (10 nM; Sigma) (GRE-Luc) and
further incubated at 37 °C for 16 h cells. Luciferase activity
of cell lysates was determined luminometrically by a luciferase assay
system (Promega) as specified by the manufacturer. For the analysis of
HSF-induced activation, the reporter plasmid HSE-luc was
co-transfected with 1 µg of effector plasmid coding for
HSE.
48 h after transfection the cells were assayed for luciferase activity. Transfection efficiencies were normalized by co-transfection of a plasmid expressing
-galactosidase under control of a
cytomegalovirus promoter.
-Galactosidase activity was determined
spectrophotometrically by a
-galactosidase enzyme assay system
(Promega). All transfections were performed repeatedly and in triplicate.
-32P]dCTP (3000 Ci/mmol; Amersham
Pharmacia Biotech). After washing with 2× SSC, 1% SDS and 0.2× SSC,
1% SDS for several times at 50 °C, hybridization signals were
detected by autoradiography.
-32P]ATP (3000 Ci/mmol; Amersham Pharmacia Biotech)
and T4 polynucleotide kinase (Promega) and purified on a Micro Bio-Spin
30 column (Bio-Rad). Following binding at room temperature for 20 min
the mixtures were loaded onto nondenaturing 4% polyacrylamide gel in
0.5 TBE (45 mM Tris borate, 1 mM EDTA). Gels
were electrophoresed for 2.5 h at 150 V, dried, and exposed for autoradiography.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
PK) and PK-resistant PrPSc
(Fig. 1A, + PK). After thermal challenge
(44 °C, 20 min), only N2a cells but none of the ScN2a cell lines
expressed inducible Hsp72 (Fig. 1A,
-Hsp72)
and Hsp28 (data not shown). Thus, at least three different ScN2a cell
lines showed defective expression of the two inducible stress proteins
Hsp72 and Hsp28.

View larger version (34K):
[in a new window]
Fig. 1.
Three different ScN2a cell lines lack a
functional heat shock response. A, monolayer N2a and
ScN2a cells of three independently established cell lines (ScN2a,
I-III) were solubilized in cold buffer A (0.5% Triton
X-100 and 0.5% sodium deoxycholate in PBS). The lysates were
mock-incubated (
PK) or incubated with proteinase K
(+ PK) and centrifuged to obtain the detergent soluble
(Supernatant) and insoluble (Pellet) protein
fraction. PrP present in each fraction was detected in immunoblotting
experiments using the anti-PrP antibody A4 (
-PrP).
Expression of the heat-inducible Hsp72 was analyzed in protein lysates
prepared from N2a and ScN2a I-III cells after exposure to heat
(44 °C, 20 min) and subsequent cultivation at 37 °C for 16 h
using the anti-Hsp72 antibody C92 (
-hsp72). B,
N2a and ScN2a I cells were lysed by boiling in Laemmli sample buffer,
and equal amounts of protein were analyzed by Western blotting using
antibodies against Hsp73, Hsp90, and p23.
HSF.
HSF contains a
deletion in the regulatory domain (
202-316) and is constitutively
active (24). Co-transfection of HSE-Luc and wtHSF resulted in weak
activation of HSE-Luc in both N2 and ScN2a cells (Fig. 2B,
wtHSF). The luciferase activity in wtHSF-expressing ScN2a
cells was comparable with the activity in ScN2a cells subjected to a
severe heat shock (Fig. 2A). Of note, overexpression of
wtHSF generates trimeric HSF1, which, however, is not sufficient to induce expression from the endogenous Hsp72 promoter (Fig.
3B). We therefore concluded
that the weak activation of HSE-Luc in ScN2a cells after a severe heat
shock resulted from trimeric HSF1, which is incompetent to
transactivate the endogenous Hsp72 promoter. Indeed, HSF1 trimers were
generated in ScN2a cells after a heat stress, as determined by
electrophoretic mobility shift assays (see Fig. 5A).

View larger version (19K):
[in a new window]
Fig. 2.
Activation of an exogenous HSE promoter by
heat and
HSF. A and
C, N2a and ScN2a cells were transiently co-transfected with
a reporter plasmid encoding luciferase under the control of a HSE
promoter (HSE-Luc) and a plasmid encoding
-galactosidase under the
control of a cytomegalovirus promoter. 24 h after transfection,
the cells were subjected to a heat shock (44 °C) for the time
indicated, returned to 37 °C, and harvested after additional 16 h. A, luciferase activity in the cell extracts was
quantified as described under "Experimental Procedures." Luciferase
activity in cells cultivated constantly at 37 °C was set as 1. B, N2a and ScN2a cells were transiently co-transfected with
HSE-luc and a plasmid encoding either wtHSF1 or a constitutively active
HSF1 mutant (
HSF) under the control of a cytomegalovirus promoter.
After transfection cells were cultivated at 37 °C for 24 h;
luciferase activity was measured and graphically presented as described
for A. C,
-galactosidase activity in the same
extracts as shown for A was quantified as described under
"Experimental Procedures." D, N2a and ScN2a cells were
transfected with a plasmid coding for luciferase under the control of a
constitutive SV40 promoter and treated in parallel exactly like the
cells analyzed for A. All graphs represent the quantitative
analysis of at least three independently conducted experiments.

View larger version (25K):
[in a new window]
Fig. 3.
Geldanamycin restores the stress response in
ScN2a cells. N2a and ScN2a cells were grown on glass coverslips,
and expression of Hsp72 was determined by indirect immunofluorescence
using the anti-Hsp72 antibody C92. A, cells were cultivated
at 37 °C (37 °C), subjected to 44 °C for 20 min
(44 °C), subjected to geldanamycin (5 µM,
3 h) (GA), or subjected to a heat shock 2 h after
administration of GA (GA + 44 °C). Subsequent to the
stress treatment, the cells were further cultivated in fresh cell
culture medium and analyzed after an additional 16 h at 37 °C.
B, ScN2a cells grown on glass coverslips were transfected
with a plasmid encoding wtHSF1 or the constitutively active
HSF1
mutant (
HSF). Expression of Hsp72 was analyzed by
indirect immunofluorescence of cells grown at 37 °C
(37 °C) or subjected to 44 °C for 20 min
(44 °C) as described for A. C, N2a
and ScN2a cells were incubated with or without GA (5 µM,
3 h). The expression pattern of Hsp90 was analyzed by indirect
immunofluorescence. D, N2a and ScN2a cells were transfected
with GRE-Luc and incubated with dexamethasone (10 nM for 16 h. Then luciferase activity of cell lysates was quantified
luminometrically.
HSF construct with HSE-Luc resulted in an
extremely high luciferase activity in N2a and ScN2a cells even without
applying a heat shock. (Fig. 2B,
HSF),
Notably, overexpression of
HSF was sufficient to induce expression
of Hsp72 in ScN2a cells (Fig. 3B). To verify that the
different levels of luciferase activity measured in our stress
activation assay reflected stress-regulated promoter activity and not
differences in transfection efficiencies or instability of luciferase,
two different control experiments were performed. In the analysis shown
in Fig. 2C, a plasmid encoding
-galactosidase under
control of a cytomegalovirus promoter was co-transfected. Similar
levels of
-galactosidase in N2a and ScN2a cells indicated similar
transfection efficiencies. In addition, N2a and ScN2a cells were
transfected in parallel with a plasmid coding for luciferase under the
control of a constitutive SV40 promoter and treated exactly like the
cells analyzed in Fig. 2A. The results of this experiment
demonstrated that activity of luciferase was not different in the ScN2a
background (Fig. 2D).
HSF and wtHSF Overcomes the Impaired
Activation of Endogenous HSF1 in ScN2a Cells--
The experiments
described above supported the hypothesis that HSF1 regulation is
defective in ScN2a cells. Moreover, they showed that the defect could
be corrected by exposure to geldanamycin. To further probe the defect
in the stress response in ScN2a cells, we transiently transfected
expression constructs for either constitutively active
HSF or
wtHSF1. Hsp72 expression was detected by indirect immunofluorescence in
unstressed cells or in cells exposed to a heat shock (44 °C for 20 min). In agreement with the co-transfection experiments discussed
before, ScN2a cells transfected with the
HSF construct expressed
Hsp72 without stress (Fig. 3B,
HSF, 37 °C). Note that in this case the nonuniform pattern of
Hsp72-positive cells reflected transfection efficiency, which was
verified by co-transfection of a plasmid expressing green fluorescent
protein (data not shown). After a heat shock, no further increase in
Hsp72-positive cells was seen, corroborating our previous results that
untransfected ScN2a cells could not mount a heat shock response. No
Hsp72 expression was observed in unstressed ScN2a cells overexpressing
exogenous wild type HSF1 (Fig. 3B, wt HSF,
37 °C), even though overexpressed wild type HSF1 was
largely present as trimers (data not shown). In contrast, a moderate
level of Hsp72 expression was observed in HSF1-overexpressing ScN2a
cells that had been heat-treated (Fig. 3B, wt
HSF, 44 °C). Taken together, we have established three ways of inducing Hsp72 expression in ScN2a cells. Overexpression of
HSF resulted in a stress-independent expression of Hsp72, and
overexpression of wtHSF1 or treatment with the Hsp90-binding drug
geldanamycin restored the heat stress inducibility of Hsp72 expression.

View larger version (31K):
[in a new window]
Fig. 4.
Geldanamycin induces expression of
Hsp72-specific mRNA in ScN2a cells. A, N2a cells
were subjected to 44 °C for 20 min (hs) or incubated with
geldanamycin (5 µM, 3 h) 2 h prior to the heat
shock (hs + GA) and returned to 37 °C. At the time points
indicated cytosolic RNA was isolated and probed for Hsp72-specific
(hsp72) and PrP-specific (PrP) mRNA by
Northern blotting. B, ScN2a cells were analyzed in parallel
as described for N2a cells for A. Cytosolic RNA was isolated
2 h after the heat shock. At later time points no Hsp72-specific
mRNA was detectable (data not shown).

View larger version (49K):
[in a new window]
Fig. 5.
Geldanamycin delays HSF1 trimer
disassembly. A, N2a and ScN2a cells were subjected to
44 °C for 20 min (hs +), returned to 37 °C, and
harvested at the time points indicated (min after heat shock) by shock
freezing in liquid nitrogen. Protein extracts were prepared and probed
for HSE binding activity by electrophoretic mobility shift assays.
B, N2a and ScN2a cells were incubated with geldanamycin (5 µM, 3 h) (GA + and hs
) or
subjected to a heat shock (44 °C, 20 min) 2 h after
administration of geldanamycin (GA +, hs +). The cells were harvested
and analyzed for HSF1 trimer formation as described for A.
The time points are always indicated as hours after geldanamycin
treatment. As an example, in the case of co-treatment with geldanamycin
and heat shock (GA + and hs +) the 3 h time
point (3 h after geldanamycin) was harvested 1 h after the heat
shock. C, quantitative evaluation of HSF1 trimer formation
in N2a and ScN2a cells measured as HSE binding activity after a heat
shock in absence and in presence of geldanamycin. The relative amount
of HSF1 trimers present 20 min after the heat shock was set as
100%.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
HSF) very
efficiently induced expression of Hsp72, showing that the endogenous
Hsp72 gene in ScN2a cells has a functional promoter. This is in
contrast to some cell lines described earlier (20, 64-66) in which a
chromatin-mediated effect accounted for an impaired Hsp72 expression
after stress (67, 68). Based on the finding that in ScN2a cells HSF1
activity after stress was sufficient to induce trimer formation yet
insufficient to promote transactivation competence, we directed our
attention to the activation/deactivation pathway of HSF1.

View larger version (11K):
[in a new window]
Fig. 6.
Modulation of the heat shock response in
ScN2a cells by geldanamycin. The scheme depicts the three stage
model of the stress-induced activation of HSF1. Without geldanamycin it
appeared that trimeric HSF1 (complex II) was formed in heat-shocked
ScN2a cells; however, transition into complex III with transactivation
competence was impaired. Formation of complex III in
geldanamycin-treated ScN2a cells can be explained by two different
models. In A, the rapid deactivation of complex II and/or
III is prevented by geldanamycin. Equally plausible is model B, where
transition from complex II to complex III is stimulated by
geldanamycin. In both models the effect of geldanamycin could relate to
the inactivation of a negative regulator or to the activation of a
positive factor. Possibly, geldanamycin releases a factor from the
Hsp90 chaperone complex that might be degraded (negative regulator) or
might then be available for activation of HSF1. Different colors of
HSF1 represent the different stages of activation. ×, Hsp90
chaperone complex; GA, geldanamycin. The HSF1 complexes
might differ in terms of components present in the complex or in terms
of intramolecular modifications of HSF1-like phosphorylation.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to F. Ulrich Hartl for stimulating discussions and continuous support. We thank William J. Welch for providing the anti-Hsp72 antibody C92, Richard I. Morimoto for the DNA probe specific for Hsp72 mRNA, and Theo Rein for the GRE-Luc plasmid.
| |
FOOTNOTES |
|---|
* This work was supported by Grant TA 167/2 from the Deutsche Forschungsgemeinschaft.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Cellular Biochemistry, Max-Planck-Institut für Biochemie, D-82152
Martinsried, Germany. E-mail: tatzelt@biochem.mpg.de.
Published, JBC Papers in Press, September 26, 2001, DOI 10.1074/jbc.M104873200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Hsp, heat shock protein; HSF, heat shock transcription factor; HSE, heat shock element; PK, proteinase K; PBS, phosphate-buffered saline; wt, wild type; PrPC, cellular prion protein; PrPSc, scrapie prion protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Lindquist, S., and Craig, E. A. (1988) Annu. Rev. Genet. 22, 631-677 |
| 2. | Hartl, F. U. (1996) Nature 381, 571-579 |
| 3. | Rutherford, S. L., and Zuker, C. S. (1994) Cell 79, 1129-1132 |
| 4. | Gottesman, S., Wickner, S., and Maurizi, M. R. (1997) Genes Dev. 11, 815-823 |
| 5. | Bukau, B., and Horwich, A. L. (1998) Cell 92, 351-366 |
| 6. | Morimoto, R. I., Jurivich, D. A., Kroeger, P. E., Marthur, S. K., Murphy, S. P., Nakai, A., Sarge, K., Abravaya, K., and Sisitonen, L. T. (1994) in The biology of heat shock proteins and molecular chaperones (Morimoto, R. I. , Tissieres, A. , and Georgopoulos, C., eds) , pp. 417-455, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 7. | Buzzard, K. A., Giaccia, A. J., Killender, M., and Anderson, R. L. (1998) J. Biol. Chem. 273, 17147-17153 |
| 8. | Jaattela, M., Wissing, D., Kokholm, K., Kallunki, T., and Egeblad, M. (1998) EMBO J. 17, 6124-6134 |
| 9. | Mosser, D. D., Caron, A. W., Bourget, L., Denis-Larose, C., and Massie, B. (1997) Mol. Cell. Biol. 17, 5317-5327 |
| 10. | Parsell, D. A., and Lindquist, S. (1994) in The Biology of Heat Shock Proteins and Molecular Chaperones (Morimoto, R. I. , Tissieres, A. , and Georgopoulos, C., eds) , pp. 457-494, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 11. | Sharp, F. R., Massa, S. M., and Swanson, R. A. (1999) Trends Neurosci. 22, 97-99 |
| 12. | Yenari, M. A., Giffard, R. G., Sapolsky, R. M., and Steinberg, G. K. (1999) Mol. Med. Today 5, 525-531 |
| 13. | Heydari, A. R., Takahashi, R., Gutsmann, A., You, S., and Richardson, A. (1994) Experientia 50, 1092-1098 |
| 14. | Gabai, V. L., Meriin, A. B., Mosser, D. D., Caron, A. W., Rits, S., Shifrin, V. I., and Sherman, M. Y. (1997) J. Biol. Chem. 272, 18033-18037 |
| 15. | Baler, R., Welch, W. J., and Voellmy, R. (1992) J. Cell Biol. 117, 1151-1159 |
| 16. | Wu, C. (1995) Annu. Rev. Cell Dev. Biol. 11, 441-469 |
| 17. | Morimoto, R. I., Kroeger, P. E., and Cotto, J. J. (1996) Exs 77, 139-163 |
| 18. | Morimoto, R. I. (1998) Genes Dev. 12, 3788-3796 |
| 19. | Voellmy, R. (1996) Exs 77, 121-137 |
| 20. | Hensold, J. O., Hunt, C. R., Calderwood, S. K., Housman, D. E., and Kingston, R. E. (1990) Mol. Cell. Biol. 10, 1600-1608 |
| 21. | Price, B. D., and Calderwood, S. K. (1991) Mol. Cell. Biol. 11, 3365-3368 |
| 22. | Jurivich, D. A., Sistonen, L., Kroes, R. A., and Morimoto, R. I. (1992) Science 255, 1243-1245 |
| 23. | Bruce, J. L., Price, B. D., Coleman, C. N., and Calderwood, S. K. (1993) Cancer Res. 53, 12-15 |
| 24. | Zuo, J., Rungger, D., and Voellmy, R. (1995) Mol. Cell. Biol. 15, 4319-4330 |
| 25. | Cotto, J. J., Kline, M., and Morimoto, R. I. (1996) J. Biol. Chem. 271, 3355-3358 |
| 26. | Ali, A., Bharadwaj, S., O'Carroll, R., and Ovsenek, N. (1998) Mol. Cell. Biol. 18, 4949-4960 |
| 27. | Zou, J., Guo, Y., Guettouche, T., Smith, D. F., and Voellmy, R. (1998) Cell 94, 471-480 |
| 28. | Bharadwaj, S., Ali, A., and Ovsenek, N. (1999) Mol. Cell. Biol. 19, 8033-8041 |
| 29. | Zuo, J., Baler, R., Dahl, G., and Voellmy, R. (1994) Mol. Cell. Biol. 14, 7557-7568 |
| 30. | Green, M., Schuetz, T. J., Sullivan, E. K., and Kingston, R. E. (1995) Mol. Cell. Biol. 15, 3354-3362 |
| 31. | Duina, A. A., Kalton, H. M., and Gaber, R. F. (1998) J. Biol. Chem. 273, 18974-18978 |
| 32. | Shi, Y., Mosser, D. D., and Morimoto, R. I. (1998) Genes Dev. 12, 654-666 |
| 33. | Chang, N. T., Huang, L. E., and Liu, A. Y. (1993) J. Biol. Chem. 268, 1436-1439 |
| 34. | Erdos, G., and Lee, Y. J. (1994) Biochem. Biophys. Res. Commun. 202, 476-483 |
| 35. | Xia, W., and Voellmy, R. (1997) J. Biol. Chem. 272, 4094-4102 |
| 36. | Xia, W., Guo, Y., Vilaboa, N., Zuo, J., and Voellmy, R. (1998) J. Biol. Chem. 273, 8749-8755 |
| 37. | Kline, M. P., and Morimoto, R. I. (1997) Mol. Cell. Biol. 17, 2107-2115 |
| 38. | Knauf, U., Newton, E. M., Kyriakis, J., and Kingston, R. E. (1996) Genes Dev. 10, 2782-2793 |
| 39. | Tatzelt, J., Zuo, J. R., Voellmy, R., Scott, M., Hartl, U., Prusiner, S. B., and Welch, W. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2944-2948 |
| 40. | Voellmy, R., Ahmed, A., Schiller, P., Bromley, P., and Rungger, D. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 4949-4953 |
| 41. | Rosenhagen, M. C., Young, J. C., Wochnik, G. M., Herr, A. S., Schmidt, U., Hartl, F. U., Holsboer, F., and Rein, T. (2001) Biol. Chem. 382, 499-504 |
| 42. | Winklhofer, K. F., and Tatzelt, J. (2000) Biol. Chem. 381, 463-469 |
| 43. | Welch, W. J., and Suhan, J. P. (1986) J. Cell Biol. 103, 2035-2052 |
| 44. | Tatzelt, J., Prusiner, S. B., and Welch, W. J. (1996a) EMBO J. 15, 6363-6373 |
| 45. | Hunt, C., and Morimoto, R. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 6455-6459 |
| 46. | Baler, R., Dahl, G., and Voellmy, R. (1993) Mol. Cell. Biol. 13, 2486-2496 |
| 47. | Goldenberg, C. J., Luo, Y., Fenna, M., Baler, R., Weinmann, R., and Voellmy, R. (1988) J. Biol. Chem. 263, 19734-19739 |
| 48. | Borchelt, D. R., Taraboulos, A., and Prusiner, S. B. (1992) J. Biol. Chem. 267, 16188-16199 |
| 49. | Butler, D. A., Scott, M. R. D., Bockman, J. M., Borchelt, D. R., Taraboulos, A., Hsiao, K. K., Kingsbury, D. T., and Prusiner, S. B. (1988) J. Virol. 62, 1558-1564 |
| 50. | Caughey, B., and Raymond, G. J. (1991a) J. Biol. Chem. 266, 18217-18223 |
| 51. | Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., and Neckers, L. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8324-8328 |
| 52. | Schulte, T. W., Blagosklonny, M. V., Ingui, C., and Neckers, L. (1995) J. Biol. Chem. 270, 24585-24588 |
| 53. | Smith, D. F., Whitesell, L., Nair, S. C., Chen, S., Prapapanich, V., and Rimerman, R. A. (1995) Mol. Cell. Biol. 15, 6804-6812 |
| 54. | Blagosklonny, M. V., Toretsky, J., Bohen, S., and Neckers, L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8379-8383 |
| 55. | Chavany, C., Mimnaugh, E., Miller, P., Bitton, R., Nguyen, P., Trepel, J., Whitesell, L., Schnur, R., Moyer, J., and Neckers, L. (1996) J. Biol. Chem. 271, 4974-4977 |
| 56. | Schneider, C., Sepp-Lorenzino, L., Nimmesgern, E., Ouerfelli, O., Danishefsky, S., Rosen, N., and Hartl, F. U. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14536-14541 |
| 57. | Whitesell, L., and Cook, P. (1996) Mol. Endocrinol. 10, 705-712 |
| 58. | Grenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H. J., Schulte, T. W., Sausville, E., Neckers, L. M., and Toft, D. O. (1997) J. Biol. Chem. 272, 23843-23850 |
| 59. | Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., and Pearl, L. H. (1997) Cell 90, 65-75 |
| 60. | McIlwrath, A. J., Brunton, V. G., and Brown, R. (1996) Cancer Chemother. Pharmacol. 37, 423-428 |
| 61. | Scheibel, T., and Buchner, J. (1998) Biochem. Pharmacol. 56, 675-682 |
| 62. | Morano, K. A., Santoro, N., Koch, K. A., and Thiele, D. J. (1999) Mol. Cell. Biol. 19, 402-411 |
| 63. | Kim, H. R., Lee, C. H., Choi, Y. H., Kang, H. S., and Kim, H. D. (1999) IUBMB Life 48, 425-428 |
| 64. | Marini, A. M., Kozuka, M., Lipsky, R. H., and Nowak, T. S., Jr. (1990) J. Neurochem. 54, 1509-1516 |
| 65. | Nishimura, R. N., Dwyer, B. E., Clegg, K., Cole, R., and de Vellis, J. (1991) Brain Res. Mol. Brain Res. 9, 39-45 |
| 66. | Beck, S. C., Paidas, C. N., Tan, H., Yang, J., and De Maio, A. (1995) Am. J. Physiol. 269, R608-R613 |
| 67. | Mathur, S. K., Sistonen, L., Brown, I. R., Murphy, S. P., Sarge, K. D., and Morimoto, R. I. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8695-8699 |
| 68. | Drujan, D., and De Maio, A. (1999) Shock 12, 443-448 |
| 69. | Nadeau, K., Das, A., and Walsh, C. T. (1993) J. Biol. Chem. 268, 1479-1487 |
| 70. | Nair, S. C., Toran, E. J., Rimerman, R. A., Hjermstad, S., Smithgall, T. E., and Smith, D. F. (1996) Cell Stress Chaperones 1, 237-250 |
| 71. | Hegde, R. S., Zuo, J., Voellmy, R., and Welch, W. J. (1995) J. Cell. Physiol. 165, 186-200 |
| 72. | Kim, H. R., Kang, H. S., and Kim, H. D. (1999) IUBMB Life 48, 429-433 |
This article has been cited by other articles:
![]() |
A. Zoubeidi, A. Zardan, E. Beraldi, L. Fazli, R. Sowery, P. Rennie, C. Nelson, and M. Gleave Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity Cancer Res., November 1, 2007; 67(21): 10455 - 10465. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poulaki, E. Iliaki, N. Mitsiades, C. S. Mitsiades, Y. N. Paulus, D. V. Bula, E. S. Gragoudas, and J. W. Miller Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis FASEB J, July 1, 2007; 21(9): 2113 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al. Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling J. Neurosci., February 21, 2007; 27(8): 1868 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. McCollum, C. J. TenEyck, B. M. Sauer, D. O. Toft, and C. Erlichman Up-regulation of Heat Shock Protein 27 Induces Resistance to 17-Allylamino-Demethoxygeldanamycin through a Glutathione-Mediated Mechanism. Cancer Res., November 15, 2006; 66(22): 10967 - 10975. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Shen, J.-C. He, Y. Wang, Q.-Y. Huang, and J.-F. Chen Geldanamycin Induces Heat Shock Protein 70 and Protects against MPTP-induced Dopaminergic Neurotoxicity in Mice J. Biol. Chem., December 2, 2005; 280(48): 39962 - 39969. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bertsch, K. F. Winklhofer, T. Hirschberger, J. Bieschke, P. Weber, F. U. Hartl, P. Tavan, J. Tatzelt, H. A. Kretzschmar, and A. Giese Systematic Identification of Antiprion Drugs by High-Throughput Screening Based on Scanning for Intensely Fluorescent Targets J. Virol., June 15, 2005; 79(12): 7785 - 7791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kiachopoulos, A. Bracher, K. F. Winklhofer, and J. Tatzelt Pathogenic Mutations Located in the Hydrophobic Core of the Prion Protein Interfere with Folding and Attachment of the Glycosylphosphatidylinositol Anchor J. Biol. Chem., March 11, 2005; 280(10): 9320 - 9329. [Abstract] [Full Text] [PDF] |
||||